{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:28:55Z","timestamp":1788906535220,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.hlc.2016.12.020","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T20:47:05Z","timestamp":1489524425000},"page":"1026-1035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Creatine Phosphate Administration in Cell Energy Impairment Conditions: A Summary of Past and Present Research"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0147-1894","authenticated-orcid":false,"given":"A.V.","family":"Gaddi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Galuppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hlc.2016.12.020_bib0005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1042\/bj0210190","article-title":"The Inorganic Phosphate and a Labile Form of Organic Phosphate in the Gastrocnemius of the Frog","volume":"21","author":"Eggleton","year":"1927","journal-title":"Biochem J"},{"key":"10.1016\/j.hlc.2016.12.020_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/9780470122952.ch4","article-title":"Creatine: biosynthesis, regulation, and function","volume":"50","author":"Walker","year":"1979","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"issue":"5","key":"10.1016\/j.hlc.2016.12.020_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0006-291X(62)90008-6","article-title":"Breakdown of adenosine triphosphate during a single contraction of working muscle","volume":"8","author":"Cain","year":"1962","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.hlc.2016.12.020_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0022-2828(70)90009-X","article-title":"Functional compartmentation of ATP and creatine phosphate in heart muscle","volume":"1","author":"Gudbjarnason","year":"1970","journal-title":"J Mol Cell Cardiol"},{"issue":"21","key":"10.1016\/j.hlc.2016.12.020_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.RES.21.3.365","article-title":"Myocardial high-energy phosphate stores in cardiac hypertrophy and heart failure","author":"Pool","year":"1967","journal-title":"Circ Res"},{"issue":"3 Pt 1","key":"10.1016\/j.hlc.2016.12.020_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0002-8703(91)90527-O","article-title":"Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy","volume":"122","author":"Hardy","year":"1991","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.hlc.2016.12.020_bib0035","first-page":"453","article-title":"Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy","volume":"45","author":"Neubauer","year":"1997","journal-title":"J Investig Med"},{"issue":"3","key":"10.1016\/j.hlc.2016.12.020_bib0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0885-4505(86)90090-3","article-title":"Effect of phosphocreatine and related compounds on the phospholipid metabolism of ischemic heart","volume":"35","author":"Anyukhovsky","year":"1986","journal-title":"Biochem Med Metab Biol"},{"key":"10.1016\/j.hlc.2016.12.020_bib0045","first-page":"1","article-title":"Impaired Cerebral Mitochondrial Oxidative Phosphorylation Function in a Rat Model of Ventricular Fibrillation and Cardiopulmonary Resuscitation","volume":"2014","author":"Jun","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hlc.2016.12.020_bib0050","series-title":"International Congress on Creatine - From Basic Science to Clinical Application","first-page":"17","article-title":"A physiological view of the creatine-phosphate shuttle, exercise, and protein synthesis","author":"Bessman","year":"1999"},{"key":"10.1016\/j.hlc.2016.12.020_bib0055","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1146\/annurev.bi.54.070185.004151","article-title":"The creatine-creatine phosphate energy shuttle","volume":"54","author":"Bessman","year":"1985","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.hlc.2016.12.020_bib0060","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0002-9149(79)90177-2","article-title":"Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate","volume":"44","author":"Hearse","year":"1979","journal-title":"Am J Card"},{"issue":"97","key":"10.1016\/j.hlc.2016.12.020_bib0065","first-page":"428","article-title":"Recovery of left ventricular function after graded cardiac ischemia as predicted by myocardial P-31 nuclear magnetic resonance","author":"Whitman","year":"1985","journal-title":"Surg"},{"issue":"11","key":"10.1016\/j.hlc.2016.12.020_bib0070","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/01.CIR.103.11.1570","article-title":"High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model","volume":"103","author":"Ye","year":"2001","journal-title":"Circ"},{"issue":"6","key":"10.1016\/j.hlc.2016.12.020_bib0075","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.CIR.86.6.1810","article-title":"31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure","volume":"86","author":"Neubauer","year":"1992","journal-title":"Circ"},{"issue":"3","key":"10.1016\/j.hlc.2016.12.020_bib0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000092767","article-title":"The relationship between plasma BNP level and the myocardial phosphocreatine\/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy","volume":"106","author":"Chida","year":"2006","journal-title":"Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2016.12.020_bib0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1172\/JCI11003","article-title":"Brain tissue responses to ischemia","volume":"106","author":"Lee","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hlc.2016.12.020_bib0090","first-page":"1133","article-title":"Myocardial ischemia, hypoxia and infarction","volume":"2","author":"Reimer","year":"1986"},{"issue":"Suppl:Il2-12","key":"10.1016\/j.hlc.2016.12.020_bib0095","article-title":"Development of cell injury in sustained acute ischemia","volume":"82","author":"Jennings","year":"1990","journal-title":"Circ"},{"key":"10.1016\/j.hlc.2016.12.020_bib0100","first-page":"1205","article-title":"Intracellular distribution of double-labelled creatine phosphate in the rabbit myocardium","volume":"37","author":"Breccia","year":"1985","journal-title":"Curr Ther Res"},{"issue":"7","key":"10.1016\/j.hlc.2016.12.020_bib0105","first-page":"505","article-title":"Distribuzione intracellulare della 14C-creatina 32P-fosfato nel miocardio di coniglio","volume":"31","author":"Fini","year":"1986","journal-title":"Cardiologia"},{"issue":"4606","key":"10.1016\/j.hlc.2016.12.020_bib0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/181419b0","article-title":"Effect of creatine phosphate administration of the cardiac adenosine triphosphate of thyroxinized rats","volume":"181","author":"Angelucci","year":"1958","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.hlc.2016.12.020_bib0115","first-page":"1763","article-title":"Molecular cellular aspects of the cardio protective mechanism of phosphocreatine","volume":"57","author":"Saks","year":"1992","journal-title":"Biokhimiia"},{"key":"10.1016\/j.hlc.2016.12.020_bib0120","series-title":"Proceedings of the international meeting \u201cCardioprotection with phosphocreatine in cardiology and cardiosurgery\u201d","first-page":"11","article-title":"Further studies on the role of ATP and phosphocreatine in cardiac cells. Biochemical basis of pharmacological action of phosphocreatine","author":"Saks","year":"1989"},{"key":"10.1016\/j.hlc.2016.12.020_bib0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0005-2736(88)90557-3","article-title":"Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and \u201cgas-dissected\u201d membranes","volume":"943","author":"Post","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hlc.2016.12.020_bib0130","series-title":"Pathophysiology of severe ischemic myocardial injury","first-page":"60","author":"Piper","year":"1990"},{"key":"10.1016\/j.hlc.2016.12.020_bib0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-2828(89)91494-6","article-title":"Protection of isolated rat heart from oxidative stress by exogenous CrP","volume":"21","author":"Zucchi","year":"1989","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hlc.2016.12.020_bib0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/25.2.164","article-title":"Improvement in contractile recovery of isolated rat heart after cadioplegic ischemic arrest with endogenous phosphocreatine: Involvement of antiperoxidative effect","volume":"25","author":"Conorev","year":"1991","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.hlc.2016.12.020_bib0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.14740\/jocmr2087w","article-title":"Protective effects of phosphocreatine administered post- treatment combined with ischemic post-conditioning on rat hearts with myocardial ischemia\/reperfusion injury","volume":"7","author":"Zhang","year":"2015","journal-title":"J Clin Med Res"},{"issue":"3","key":"10.1016\/j.hlc.2016.12.020_bib0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10517-015-2749-4","article-title":"Effect of phosphocreatine and ethylmethylhydroxypyridine succinate on the expression of bax and bcl-2 proteins in left-ventricular cardiomyocytes of spontaneously hypertensive rats","volume":"158","author":"Azova","year":"2015","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"10.1016\/j.hlc.2016.12.020_bib0155","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3892\/mmr.2014.2219","article-title":"Cardio protective effects of phosphocreatine on myocardial cell ultrastructure and calcium-sensing receptor expression in the acute period following high-level spinal cord injury","volume":"10","author":"Chen","year":"2014","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.hlc.2016.12.020_bib0160","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-5223(19)36192-6","article-title":"Protection of ischemic myocardium by exogenous phosphocreatine. II. Clinical, ultrastructural, and biochemical evaluations","volume":"94","author":"Semenovsky","year":"1987","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hlc.2016.12.020_bib0165","series-title":"2nd International Symposium on Cardiac Surgery","first-page":"179","article-title":"Protezione miocardica: uso del creatin fosfato addizionato alla soluzione cardioplegica. Heart Surg 1987","author":"D\u2019alessandro","year":"1987"},{"issue":"2","key":"10.1016\/j.hlc.2016.12.020_bib0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/1010-7940(91)90004-4","article-title":"Creatine phosphate (Neoton) as an additive to St. Thomas\u2019 Hospital cardioplegic solution (Plegisol). Results of a clinical study","volume":"5","author":"Chambers","year":"1991","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2016.12.020_bib0175","series-title":"Heart Surgery","first-page":"442","article-title":"Paediatric cold heart surgery: experience with creatine phosphate added to cardioplegic solution","author":"Cossolini","year":"1993"},{"issue":"2","key":"10.1016\/j.hlc.2016.12.020_bib0180","first-page":"38","article-title":"Intraoperative myocardial protection with extracellular cardioplegic solutions in patients with cardiac valve diseases","volume":"23","author":"Zhidkov","year":"2007","journal-title":"Anesteziol Reanimatol"},{"issue":"1","key":"10.1016\/j.hlc.2016.12.020_bib0185","first-page":"38","article-title":"Study of the myocardial effect of creatine phosphate cardioplegia","volume":"24","author":"Tao","year":"2001","journal-title":"Shanghai Med J"},{"issue":"1","key":"10.1016\/j.hlc.2016.12.020_bib0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MCA.0b013e32835aab95","article-title":"Role of creatine phosphate as a myoprotective agent during coronary artery bypass graft in elderly patients","volume":"24","author":"Guo-Han","year":"2013","journal-title":"Coron Artery Dis"},{"issue":"6 Suppl 1","key":"10.1016\/j.hlc.2016.12.020_bib0195","first-page":"75","article-title":"The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery","volume":"37","author":"Cisowski","year":"1996","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.hlc.2016.12.020_bib0200","series-title":"Proceedings of the International Meeting \u201cCardioprotection with Posphocreatine in Cardiology and Cardiac Surgery\u201d","first-page":"365","article-title":"Protezione miocardica in cardiochirurgia con creatina fosfato nel periodo perioperatorio","author":"Donegani","year":"1989"},{"issue":"4","key":"10.1016\/j.hlc.2016.12.020_bib0205","first-page":"199","article-title":"The use of systemic phosphocreatine in heart surgery","volume":"58","author":"Pagani","year":"1992","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.hlc.2016.12.020_bib0210","first-page":"34","article-title":"Evaluating the effectiveness of Neoton in the postoperative period","volume":"4","author":"Hapy","year":"2011","journal-title":"J Intensive Care"},{"issue":"4","key":"10.1016\/j.hlc.2016.12.020_bib0215","first-page":"25","article-title":"Results of exogenous phosphocreatine use in coronary artery bypass surgery using extracorporeal circulation system in patients with reduced myocardial flow reserves","volume":"7","author":"Barayev","year":"2012","journal-title":"Bull Nat Med Surg C NI Pirogov"},{"issue":"2","key":"10.1016\/j.hlc.2016.12.020_bib0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0002-8703(88)90611-4","article-title":"Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction","volume":"116","author":"Ruda","year":"1988","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.hlc.2016.12.020_bib0225","first-page":"136","article-title":"The effect of creatine phosphate (Neoton) in acute myocardial infarct (a prospective multicenter pilot study)","volume":"39","author":"Stejfa","year":"1993","journal-title":"Vnit\u0159n\u00ed L\u00e9ka\u0159stv\u00ed"},{"key":"10.1016\/j.hlc.2016.12.020_bib0230","first-page":"345","article-title":"La fosfocreatina nell\u2019infarto miocardico acuto: studio randomizzato multicentrico","volume":"11","author":"Reimers","year":"1994","journal-title":"Il Cuore"},{"key":"10.1016\/j.hlc.2016.12.020_bib0235","first-page":"91","article-title":"Analysis of phosphocreatine on the evolution of ischaemic lesions in acute myocardial infarction","volume":"4","author":"Coraggio","year":"1987","journal-title":"Farm Terap"},{"issue":"1","key":"10.1016\/j.hlc.2016.12.020_bib0240","first-page":"91","article-title":"Creatinfosfato nella fase acuta dell\u2019infarto miocardico. Risultati preliminari di uno studio clinico","volume":"4","author":"Cini","year":"1987","journal-title":"Il Cuore"},{"key":"10.1016\/j.hlc.2016.12.020_bib0245","series-title":"Proceedings of the International Meeting \u201cCardioprotection with Phosphocreatine in Cardiology and Cardiac Surgery\u201d","first-page":"139","article-title":"Clinical evaluation of phosphocreatine effect during acute myocardial infarction: A multicenter study","author":"Raisaro","year":"1989"},{"issue":"5","key":"10.1016\/j.hlc.2016.12.020_bib0250","first-page":"591","article-title":"Combined use of creatine phosphate and nifedipine for treatment of patients with acute myocardial infarction","volume":"50","author":"Camilova","year":"1991","journal-title":"Curr Ther Res"},{"issue":"1","key":"10.1016\/j.hlc.2016.12.020_bib0255","first-page":"19","article-title":"Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction","volume":"71","author":"Perepech","year":"1993","journal-title":"Klin Med"},{"issue":"9","key":"10.1016\/j.hlc.2016.12.020_bib0260","first-page":"50","article-title":"Neoton and thrombolytic therapy of myocardial infarction","volume":"73","author":"Perepech","year":"2001","journal-title":"Ter Arkh"},{"key":"10.1016\/j.hlc.2016.12.020_bib0265","first-page":"39","article-title":"Terapia con creatina fosfato nel paziente con insufficienza cardiaca in fase di scompenso","volume":"10","author":"Grazioli","year":"1989","journal-title":"G Ital Ric Clin Ter"},{"key":"10.1016\/j.hlc.2016.12.020_bib0270","first-page":"649","article-title":"Effect of phosphocreatine in congestive heart failure","volume":"51","author":"Andreev","year":"1992","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.hlc.2016.12.020_bib0275","first-page":"29","article-title":"Effects of phosphocreatine on plasma brain natriuretic peptide level and left ventricular function in patients with heart failure","volume":"16","author":"Wang","year":"2008","journal-title":"PJCCPVD"},{"issue":"suppl. 3","key":"10.1016\/j.hlc.2016.12.020_bib0280","first-page":"A222","article-title":"Efficiency of Creatine Phosphate Sodium and Hyzaar in hypertensive patients with diastolic dysfunction","volume":"99","author":"Ying","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2016.12.020_bib0285","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0140-6736(92)92563-U","article-title":"Editorial: Skeletal muscle in heart failure","volume":"340","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2016.12.020_bib0290","doi-asserted-by":"crossref","first-page":"29C","DOI":"10.1016\/0002-9149(91)90073-T","article-title":"Adaptive changes in the periphery and their therapeutic consequences","volume":"67","author":"Drexler","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2016.12.020_bib0295","first-page":"1364","article-title":"Skeletal muscle failure in heart failure","volume":"85","author":"Drexler","year":"1992","journal-title":"Circ"},{"key":"10.1016\/j.hlc.2016.12.020_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.med.47.1.241","article-title":"Explaining fatigue in congestive heart failure","volume":"47","author":"Drexler","year":"1996","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.hlc.2016.12.020_bib0305","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.78.2.320","article-title":"Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow","volume":"78","author":"Massie","year":"1988","journal-title":"Circ"},{"key":"10.1016\/j.hlc.2016.12.020_bib0310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-201x.2001.00830.x","article-title":"Skeletal muscle disorders in heart failure","volume":"171","author":"Lunde","year":"2001","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.hlc.2016.12.020_bib0315","first-page":"67","article-title":"Creatine phosphate in the rehabilitation of patients with muscle hypotonotrophy of the lower extremity","volume":"46","author":"Satolli","year":"1989","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.hlc.2016.12.020_bib0320","first-page":"107","article-title":"Efficacia della creatina fosfato nel trattamento della ipotonotrofia da non uso della muscolatura scheletrica","volume":"12","author":"Agnese","year":"1992","journal-title":"Ort e Traum Oggi"},{"key":"10.1016\/j.hlc.2016.12.020_bib0325","first-page":"115","article-title":"Valutazione del recupero del trofismo muscolare in pazienti anziani con frattura di femore trattati con creatina fosfato e fisiokinesiterapia","volume":"139","author":"Pirola","year":"1991","journal-title":"Clin Ter"},{"key":"10.1016\/j.hlc.2016.12.020_bib0330","first-page":"397","article-title":"Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schonlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels","volume":"11","author":"Zhang","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.hlc.2016.12.020_bib0335","first-page":"19","article-title":"Clinical Analysis on the Treatment of Pediatric Myocarditis by Neoton","volume":"23","author":"Yang","year":"2001","journal-title":"Beijing Medical Journal"},{"issue":"15","key":"10.1016\/j.hlc.2016.12.020_bib0340","first-page":"2856","article-title":"124 cases of clinical analysis of children with viral myocarditis","volume":"19","author":"Niu","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.hlc.2016.12.020_bib0345","first-page":"172","article-title":"Treatment of myocardial damage with creatine phosphate following neonatal asphyxia: a meta-analysis","volume":"14","author":"Miao","year":"2012","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"2","key":"10.1016\/j.hlc.2016.12.020_bib0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0003319713515996","article-title":"The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention","volume":"66","author":"Ke-Wu","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.hlc.2016.12.020_bib0355","first-page":"53","article-title":"Asset of creatine phosphate for cardiocerebral syndrome treatment in acute myocardial infarction in old age","volume":"134","author":"Weber","year":"1992","journal-title":"Cas L\u00e9k Ces"},{"key":"10.1016\/j.hlc.2016.12.020_bib0360","first-page":"7","article-title":"Creatine phosphate in the treatment of acute ischemic stroke","volume":"75","author":"Skrivanek","year":"1995","journal-title":"Prakticky Lekar"},{"key":"10.1016\/j.hlc.2016.12.020_bib0365","series-title":"Proceedings of the \u201c13th International Czech and Slovak Neurovascular Symposium\u201d","article-title":"SPECT findings in patients with acute stroke treated with NEOTON","author":"Bakala","year":"1995"},{"key":"10.1016\/j.hlc.2016.12.020_bib0370","first-page":"397","article-title":"H. W. Clinical Observation and Blood Gas Changes after the Treatment of Neoton in Neonates with Moderate or Severe Hypoxic Ischaemic Encephalopathy","volume":"11","author":"Zhang","year":"2004","journal-title":"Pediatr Emerg Med"},{"issue":"2","key":"10.1016\/j.hlc.2016.12.020_bib0375","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12325-011-0091-4","article-title":"Creatine phosphate: pharmacological and clinical perspectives","volume":"29","author":"Strumia","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.hlc.2016.12.020_bib0380","first-page":"ivw171","article-title":"Cardiac protection with phosphocreatine: a meta-analysis","author":"Landoni","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"10.1016\/j.hlc.2016.12.020_bib0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jon.12074","article-title":"Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson\u2019s disease","volume":"25","author":"Weiduschat","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.hlc.2016.12.020_bib0390","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchromb.2014.03.008","article-title":"Simultaneous determination of creatine phosphate, creatine and 12 nucleotides in rat heart by LC-MS\/MS","volume":"958","author":"Wang","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"10.1016\/j.hlc.2016.12.020_bib0395","doi-asserted-by":"crossref","first-page":"e0127918","DOI":"10.1371\/journal.pone.0127918","article-title":"HEPNet: A Knowledge Base Model of Human Energy Pool Network for Predicting the Energy Availability Status of an Individual","volume":"10","author":"Sengupta","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617300951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617300951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T19:54:09Z","timestamp":1719086049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950617300951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1443950617300951"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2016.12.020","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creatine Phosphate Administration in Cell Energy Impairment Conditions: A Summary of Past and Present Research","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2016.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}